Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
733.51
+8.64 (+1.19%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,009,365
Open
723.48
Bid (Size)
733.17 (3)
Ask (Size)
734.99 (1)
Prev. Close
724.87
Today's Range
721.00 - 737.45
52wk Range
380.77 - 800.78
Shares Outstanding
N/A
Dividend Yield
0.62%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SPDR ETF Report For Friday, April 26
Today 1:15 EDT
Via
Talk Markets
Topics
ETFs
Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week'
April 26, 2024
Jim Cramer has highlighted upcoming significant events for investors, including earnings from major companies like Apple and Amazon, and key economic indicators such as the Federal Reserve meeting and...
Via
Benzinga
Topics
Economy
Exposures
Economy
Interest Rates
Performance
YTD
+23.86%
+23.86%
1 Month
-5.74%
-5.74%
3 Month
+14.75%
+14.75%
6 Month
+30.93%
+30.93%
1 Year
+87.91%
+87.91%
More News
Read More
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
April 26, 2024
Via
Investor's Business Daily
Dividend Legends: 3 Stocks With Over 100 Years of Payouts
April 25, 2024
Via
InvestorPlace
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
Via
Investor's Business Daily
Market Whales and Their Recent Bets on LLY Options
April 23, 2024
Via
Benzinga
Don’t Miss Out! 3 Top-Tier Blue-Chip Growth Stocks for Your Must-Buy List
April 25, 2024
Via
InvestorPlace
Which Companies Will Join the Trillion-Dollar Team in 2024? Our 3 Best Guesses
April 24, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
April 24, 2024
Via
Benzinga
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
April 24, 2024
Via
The Motley Fool
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
Via
InvestorPlace
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
REITs Q1 Earnings Begin On Solid Note
April 23, 2024
Via
Benzinga
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
Via
InvestorPlace
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
April 22, 2024
Via
Benzinga
7 High-Flying Stocks That Are Majorly Overdue for a Pullback
April 22, 2024
Via
InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
Via
Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
6 Stocks Positioned to Soar as Investors Focus on MASH
April 22, 2024
Via
TheNewswire.com
Capturing Consumer Spending on Health Care with XLV
April 22, 2024
Via
News Direct
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
April 20, 2024
Via
The Motley Fool
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
Via
The Motley Fool
SPDR ETF Report For Friday, April 19
April 20, 2024
Via
Talk Markets
Topics
ETFs
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
April 19, 2024
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.